Emily Golden

6 Verdun Street
Nedlands, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.

Journal: The Journal of pathology

Published: October 28, 2025

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

Journal: Nature communications

Published: October 31, 2020

Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress.

Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress.

Journal: Free radical research

Published: January 07, 2020

Rab GTPases: Emerging Oncogenes and Tumor Suppressive Regulators for the Editing of Survival Pathways in Cancer.

Rab GTPases: Emerging Oncogenes and Tumor Suppressive Regulators for the Editing of Survival Pathways in Cancer.

Journal: Cancers

Published: December 20, 2019

Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer.

Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer.

Journal: NPJ precision oncology

Published: October 09, 2019

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics.

Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics.

Journal: Oncogene

Published: July 24, 2019

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: September 19, 2018

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers.

Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers.

Journal: Oncogene

Published: December 03, 2017

Computational insights for the hydride transfer and distinctive roles of key residues in cholesterol oxidase.

Computational insights for the hydride transfer and distinctive roles of key residues in cholesterol oxidase.

Journal: Scientific reports

Published: July 31, 2017

An extended N-H bond, driven by a conserved second-order interaction, orients the flavin N5 orbital in cholesterol oxidase.

An extended N-H bond, driven by a conserved second-order interaction, orients the flavin N5 orbital in cholesterol oxidase.

Journal: Scientific reports

Published: September 27, 2016

Production and characterization of recombinant perdeuterated cholesterol oxidase.

Production and characterization of recombinant perdeuterated cholesterol oxidase.

Journal: Analytical biochemistry

Published: April 18, 2015

High-resolution structures of cholesterol oxidase in the reduced state provide insights into redox stabilization.

High-resolution structures of cholesterol oxidase in the reduced state provide insights into redox stabilization.

Journal: Acta crystallographica. Section D, Biological crystallography

Published: September 25, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026